Only one out of 10,000 potential chemicals that are evaluated for drug discovery ever reach the market, and 40% of the compounds that begin animal trials will fail due to toxicity. Therefore, ...

Avance Biosciences today announced the opening of its new Potency and Cell-Based Assay Center of Excellence, a purpose-built facility designed to expand and centralize the company's capabilities in ...

According to research by SNS Insider, the U.S. Cell Analysis Market is projected to grow at a CAGR of 9.77%, Fueled by strong biotechnology capabilities, expanding precision medicine initiatives & ...

The primary causes of disability and mortality in the US are chronic diseases such as cancer, neurodegenerative disorders, cardiovascular disease, obesity, arthritis, and diabetes. The increase in ...

Cell viability constitutes a fundamental measure in biomedical research, serving as an essential indicator of cellular health, metabolic activity and the efficacy of pharmacological treatments. Among ...

Innovative and cutting-edge technology transforms functional live-cell analysis by enabling precise, flexible, and scalable end-to-end immuno-oncology, antibody, and cell therapy discovery.

The Stagljar Lab is a global leader in proteomics and chemical genomics, specializing in unraveling protein-protein interactions of human membrane proteins. Pivotal in cancer and rare genetic diseases ...

Scientists use multi-day live cell assays to monitor cell growth, viability, and cytotoxicity when evaluating the effects of drug treatment. However, maintaining consistent cell health over time ...

This article is based on a poster originally authored by Blaise Louis, Serena Belluschi, Daniel Weekes, Tom Mitchell, Holly Herbert, Tarun Vemulkar and Jeroen Verheyen, which was presented at ELRIG ...

The Center supports clients across the development and manufacturing of biologics, RNA therapeutics, vaccines, and cell and gene therapies.